$ATAO
ALTAIR INTERNATIONAL CORP.

2023 Q2 Form 10-Q Financial Statement

#000155479523000262 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $40.91K -$1.750K
YoY Change -71.11% -101.29%
% of Gross Profit
Research & Development $10.89K
YoY Change 38.37%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $40.91K $9.150K
YoY Change -71.11% -93.61%
Operating Profit -$40.91K
YoY Change -71.11%
Interest Expense $34.38K -$36.24K
YoY Change -46.15% -18.56%
% of Operating Profit
Other Income/Expense, Net -$130.1K -$916.3K
YoY Change 133.53% -7501.05%
Pretax Income -$171.0K -$1.086M
YoY Change -13.35% 327.13%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$171.0K -$1.086M
YoY Change -13.35% 327.13%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.05
COMMON SHARES
Basic Shares Outstanding 612.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.74K $28.90K
YoY Change -3.59% 38.15%
Cash & Equivalents $28.74K $28.90K
Short-Term Investments
Other Short-Term Assets $3.990K $7.980K
YoY Change -97.78% -97.04%
Inventory
Prepaid Expenses $3.990K
Receivables
Other Receivables
Total Short-Term Assets $32.73K $36.88K
YoY Change -84.4% -87.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $32.73K $36.88K
Total Long-Term Assets $0.00 $0.00
Total Assets $32.73K $36.88K
YoY Change -84.4% -87.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.761K $3.500K
YoY Change -71.9%
Accrued Expenses $41.97K $29.39K
YoY Change 791.08% 636.41%
Deferred Revenue
YoY Change
Short-Term Debt $93.32K $62.01K
YoY Change -33.23% -41.09%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $349.9K $183.1K
YoY Change 6.74% -33.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $349.9K $183.1K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $349.9K $183.1K
YoY Change 6.74% -33.54%
SHAREHOLDERS EQUITY
Retained Earnings -$17.29M -$17.12M
YoY Change 11.08% 11.39%
Common Stock $24.69K $24.69K
YoY Change -95.87% -95.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$317.2K -$146.2K
YoY Change
Total Liabilities & Shareholders Equity $32.73K $36.88K
YoY Change -84.4% -87.32%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$171.0K -$1.086M
YoY Change -13.35% 327.13%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$25.16K -$26.62K
YoY Change -3.64% -34.43%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $25.00K 30.00K
YoY Change -28.57% -42.86%
NET CHANGE
Cash From Operating Activities -$25.16K -26.62K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities $25.00K 30.00K
Net Change In Cash -$158.00 3.380K
YoY Change -101.78% -71.6%
FREE CASH FLOW
Cash From Operating Activities -$25.16K -$26.62K
Capital Expenditures $0.00
Free Cash Flow -$26.62K
YoY Change -34.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001570937
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022Q2 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17287485 usd
CY2023Q2 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
ALTAIR INTERNATIONAL CORP.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity File Number
EntityFileNumber
333-190235
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0385465
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
322 North Shore Drive
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Building 1B, Suite 200
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsburgh
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15212
CY2023Q2 dei City Area Code
CityAreaCode
412
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
770-3140
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24692449 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28739 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28897 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3990 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
7980 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
32729 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
36877 usd
CY2023Q2 us-gaap Assets
Assets
32729 usd
CY2023Q1 us-gaap Assets
Assets
36877 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5761 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3500 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25500 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
14165 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
14165 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
6967 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3889 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
79150 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
47844 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
208836 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
88169 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
349879 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
183067 usd
CY2023Q2 us-gaap Liabilities
Liabilities
349879 usd
CY2023Q1 us-gaap Liabilities
Liabilities
183067 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24692449 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24692449 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24692449 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24692449 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
24693 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
24693 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16945642 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16945642 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17287485 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17116525 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-317150 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-146190 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32729 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36877 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12000 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
102000 usd
CY2023Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
7500 usd
CY2022Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
7500 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21409 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32108 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
40909 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
141608 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-40909 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-141608 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
34384 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
63855 usd
CY2023Q2 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
-84795 usd
CY2022Q2 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
14315 usd
CY2023Q2 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
10872 usd
CY2022Q2 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
6149 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-130051 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-55689 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-170960 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-197297 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-170960 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-197297 usd
CY2023Q2 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.01
CY2022Q2 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.01
CY2023Q2 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
24692449 shares
CY2022Q2 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
23807191 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-146190 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-170960 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-317150 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
15451 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
63861 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-197297 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-117985 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-170960 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-197297 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
31306 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
60001 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
90000 usd
CY2023Q2 ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
10872 usd
CY2022Q2 ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
6149 usd
CY2023Q2 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
-84795 usd
CY2022Q2 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
14315 usd
CY2023Q2 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
3990 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2261 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-20500 usd
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
9500 usd
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5000 usd
CY2023Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3078 usd
CY2022Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3854 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25158 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26108 usd
CY2023Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
25000 usd
CY2022Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
35000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-158 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8892 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28897 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20917 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28739 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29809 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
63861 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zkU16D9lqYL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_865_za4HNVJAawg9">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p>
CY2023Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zzaJXHPr4t31" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86B_zDe4xBU0ABMl">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p>
CY2023Q2 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
35872 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
84795 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
208836 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
88169 usd
CY2023Q2 us-gaap Share Price
SharePrice
0.11
CY2022Q2 us-gaap Share Price
SharePrice
0.051
CY2023Q2 ATAO Conversion Price Minimum
ConversionPriceMinimum
0.07
CY2023Q2 ATAO Conversion Price Maximum
ConversionPriceMaximum
0.08
CY2023 ATAO Conversion Price Minimum
ConversionPriceMinimum
0.015
CY2023 ATAO Conversion Price Maximum
ConversionPriceMaximum
0.056
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
2.5212 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
3.7339 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.8753 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.0008 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0543 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0547 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0464 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0494 pure
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y3M
CY2023Q2 ATAO Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
P0Y11M15D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y1M17D
CY2023 ATAO Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
P0Y11M26D
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 25
CY2023Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
500000000 shares
CY2023Q2 ATAO Common Stock Reclassed To Additional Paid In Capital
CommonStockReclassedToAdditionalPaidInCapital
592619 usd
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
40000 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2023Q2 ATAO Aggregate Fair Value Of Warrants
AggregateFairValueOfWarrants
180000 usd
CY2023Q2 ATAO Warrants Estimates Used Stock Price
WarrantsEstimatesUsedStockPrice
4.50
CY2023Q2 ATAO Warrants Estimates Used Exercise Price
WarrantsEstimatesUsedExercisePrice
0.25
CY2023Q2 ATAO Warrants Estimates Used Risk Free Rate
WarrantsEstimatesUsedRiskFreeRate
0.0157 pure
CY2023Q2 ATAO Warrants Estimates Used Volatility
WarrantsEstimatesUsedVolatility
7.3546 pure
CY2023Q2 us-gaap Officers Compensation
OfficersCompensation
10000 usd
CY2022Q2 us-gaap Officers Compensation
OfficersCompensation
12000 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
20000 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
18000 usd
CY2022Q2 ATAO Stock Issued During Period Shares Related Parties2
StockIssuedDuringPeriodSharesRelatedParties2
400000 shares
CY2022Q2 ATAO Stock Issued During Period Price Per Share Related Parties2
StockIssuedDuringPeriodPricePerShareRelatedParties2
0.90
CY2022Q2 ATAO Stock Issued Related Party Non Cash Stock Compensation Expense2
StockIssuedRelatedPartyNonCashStockCompensationExpense2
360000 usd
CY2023Q2 ATAO Amounts Owed To Related Party For Director Fees
AmountsOwedToRelatedPartyForDirectorFees
15000 usd
CY2023Q1 ATAO Amounts Owed To Related Party For Director Fees
AmountsOwedToRelatedPartyForDirectorFees
7500 usd

Files In Submission

Name View Source Status
0001554795-23-000262-index-headers.html Edgar Link pending
0001554795-23-000262-index.html Edgar Link pending
0001554795-23-000262.txt Edgar Link pending
0001554795-23-000262-xbrl.zip Edgar Link pending
atao-20230630.xsd Edgar Link pending
atao0814form10q.htm Edgar Link pending
atao0814form10qexh31_1.htm Edgar Link pending
atao0814form10qexh32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
atao-20230630_def.xml Edgar Link unprocessable
atao-20230630_cal.xml Edgar Link unprocessable
atao-20230630_pre.xml Edgar Link unprocessable
atao-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
atao0814form10q_htm.xml Edgar Link completed